Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents

E-ISSN： 1873-4286|22|29|4610-4616

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.29, 2016-09, pp. : 4610-4616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Oral Antiplatelet Agents in Atherothrombotic Disease

By Ferguson James J.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1581-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

By Colwell John A.

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Hypolipidaemic and antiplatelet agents

By Kaliszan Roman Siluk Danuta Chilmonczyk Zdzislaw

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1301-1327

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Antiplatelet Agents

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 577-589

Bentham Science Publishers

Access to resources Recommend Favorite